Marburg Death Toll Rises To Six

0 Shares

The Marburg Virus, a rare disease related to the Ebola Virus, has claimed six lives so far, officials reported on Wednesday.

Edward Turyamureba, a 38-year-old resident of Kicumbi Cell, Kamuganguzi sub-county, succumbed to severe bleeding and vomiting on Tuesday evening bringing the number of deaths to six.

The first Marburg outbreak in Uganda since 2007, has left many residents of Kabale and Rukungiri Districts in fear. The viral hemorrhagic fever is highly contagious, spread through contact with wounds or bodily fluids of an infected person.

The Ministry of Health spokesperson Rukia Nakamatte said all quarantined residents will be monitored until the gestation period has finished. After an incubation period of five to 10 days, people afflicted with the virus begin to experience fever, chills, headaches and muscle pain.

Five days later, a rash on the chest, back and stomach may occur. Nausea, vomiting, chest pain, sore throat, abdominal pain and diarrhea are additional symptoms noted in some patients.

A spokesperson for the Ugandan Ministry of Health said that 34 people are being monitored for possible infection.

The disease can be contracted by people and non-human primates, and is transmitted through direct contact with the blood, body fluids and tissues of infected patients. Anyone in contact with a human being or animal that is infected is at risk.

Background

Since the marburg virus was first reported in the country, only one person has been confirmed to have contracted it since the five suspected victims were buried before tests were carried out.

Obed Ntegyereize, the first confirmed victim, is steadily recovering, after tests conducted on him on Tuesday turned out negative, health officials disclosed.

The last outbreak of Marburg in Uganda was in 2007 and killed two miners in Kamwenge and Ibanda districts while the deadliest occurrence of haemorrhagic fever was in 2000 when 425 people contracted Ebola and more than half of them died.

 

Facebook Comments
0 Shares